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The glucuronidation ofp-mtrophenol was measured in intact, saponin- and alamethicu-treated isolated mouse hepatocytes. In saponin-permeabil- 
ized cells the elevation of extrareticular UDP-glucuronic acid concentration enhanced the rate of glucuronidation threefold. When intracellular 
membranes were also permeabilized by alamethicin. a further tenfold Increase in the glucuromdation of p-nitrophenol was present. Parallel 
measurements of the ER mannose 6-phosphatase activity revealed that sapomn selectively permeabilized the plasma membrane, whereas alameth- 
icm permeabilized both plasma membrane and ER membranes The Inhibition ofp-mtrophenol glucuromdation by dbcAMP in intact hepatocytes 
was still present in saponin-treated cells and disappeared in alamethicin-permeabihzed hepatocytes. It is suggested that the permeabihty of the 
endoplasmic reticulum membrane is a major determinant of glucuromdation not only in microsomes but in isolated hepatocytes as well. 
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1. INTRODUCTION 
Glucuronidation is the major conjugation pathway in 
phase II of biotransformation. This reaction is cata- 
lyzed by the membrane-bound UDP-glucurono- 
syltransferases (UDPGT) [l]. The highest UDPGT ac- 
tivity is found in the endoplasmic reticulum (ER) mem- 
branes, but a significant activity is also present in the 
nuclear envelope. 
The activity of ER enzymes is usually measured in 
microsomal preparations in which the ER is fragmented 
into right-side-out closed vesicles [2]. One of the most 
interesting features of several enzymes of ER (e.g. 
glucose-6-phosphatase, nucleoside diphosphatase. 
UDPGT) [3-61 is the latency; their activities are low in 
native microsomes compared to microsomes treated 
with membrane-disrupting agents. This phenomenon 
can be explained either by the compartmentation or the 
conformation hypothesis; according to the first the re- 
stricted accessibility of the water-soluble substrates, i.e. 
UDP-glucuronic acid (UDPGA), synthesized in the cy- 
tosol, to the intravesicular active site of the enzymes, i.e. 
UDPGTs, is responsible for the low activity in intact 
microsomes [6]. The compartmentation model postu- 
lates that enzymes latent in microsomal fractions face 
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(at least with their catalytic site) the lumen of ER in situ. 
The conformation hypothesis, on the other hand, sug- 
gests that activation removes constraints that prevent 
full expression of enzyme activity [7]. 
The microsomal fraction is an artifact, and therefore 
the relevance of latency and the activity status of 
UDPGTs in vivo remains questionable. The aim of our 
study was to investigate whether the permeability of the 
ER membrane for UDPGA determines UDPGT activ- 
ity in isolated hepatocytes. As the cytosolic UDPGA 
level is also known to influence the UDPGT activity, we 
compared the rate of glucuronidation of p-nitrophenol 
in the presence of exogenously added UDPGA in hepa- 
tocytes the plasma membranes of which were permea- 
bilized selectively by saponin, and in hepatocytes in 
which both plasma membrane and endoplasmic reticu- 
lum membranes were permeabilized by the pore-form- 
ing antibiotic alamethicin. 
2. EXPERIMENTAL 
UDPGA (sodium salt), p-glucuromdase (type IX), saponin, alam- 
ethrcm, dibutyryl cyclic AMP, UDP-N-acetylglucosamme (sodium 
salt) and collagenase (type IV) were from Sigma. St Louis, MO, USA. 
.2. Prepurutron un~’ mcubutlon of IsG&i d mouse Leputocytes 
Isolated hepatocytes were prepared fi>m n al,: CFLP mice (25530 
g body weight) with the collagenase perfusion method as detailed 
earher [8]. Viabihty of the cells checked by the Trypan blue exclusion 
test was more than 90%. Isolated hepatocytes were resuspended (IO6 
cells/ml) in a modified Hanks’ medium [9] containmg 2.6 mM CaClz 
and mcubated at 37’C with constant bubbling of COZ/Oz (5.95. v/v). 
In some experiments, isolated hepatocytes were treated with 1 mM 
dibutyryl cyclic AMP for 5 min. 
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1.3 Permeabrkat~on of the ~11.~ 
Cells were permeabtlized m the mcubatton buffer wtth sapomn 
(0 005%) or alamethicm (usually 0.02%) for 5 min. Both treatments 
rendered plasma membrane permeable to exogenous substrates smce 
more than 95% of the cells became permeable to Trypan blue. Approx. 
60% and 90% of the (cytosolic) lactate dehydrogenase activity was 
released by saponm and dtgttonin, respecttvely. In some expertments 
the incubation buffer was replaced by a medium reflectmg the mtracel- 
lular tonic environment (KC]. 100 mM, NaCl: 20 mM. MgC12, 5 mM, 
MOPS: 20 mM. pH 7.2). 
Glucuronidatton of p-nitrophenol in Intact hepatocytes was meas- 
ured as described previously [IO] In permeabihzed cells glucuromda- 
tton of p-mtrophenol was measured m the presence of p-nitrophenol 
(100 or 500 PM) and UDPGA (4 mM). The rate of glucuromde 
formatton was calculated on the basis of aglycone disappearance ac- 
cording to Bock et al. [ll]. Mannose 6-phosphatase acttvity was eval- 
uated in the phosphate-free KCI-MOPS medium by measurmg P, 
accordmg to Anon et al. 1121. Protein was measured accordmg to 
Lowry et al. [13] using BSA as a standard 
3. RESULTS 
Glucuronidation ofp-nitrophenol was measured in (i) 
saponin treated hepatocytes and (ii) in alamethicin per- 
meabilized hepatocytes in the presence of exogenous 
UDPGA (4 mM). 0.1 mM aglycone concentration was 
chosen because the rate of p-nitrophenol glucuronida- 
tion of isolated hepatocytes is maximal at this concen- 
tration. and higher levels of p-nitrophenol inhibit its 
own conjugation [l&16]. 
Selective permeabilization of plasma membrane of 
hepatocytes by saponin enhanced the rate ofp-nitrophe- 
no1 glucuronidation threefold as compared to non-per- 
meabilized, control cells (Table I). In saponin-permea- 
bilized cells the addition of the UDPGT activator UDP- 
N-acetylglucosamine (UDPNAG; 1 mM) caused a fur- 
ther stimulation of glucuronidation. Treatment of the 
cells by the optimal concentration of alamethicin 
(0.02%) caused a tenfold activation compared to the 
saponin-treated hepatocytes (Table I). The magnitude 
of this activation was comparable with the unmasking 
effect of detergents on UDPGT activity in microsomal 
membrane [I 11. In control, non-permeabilized hepa- 
tocytes exogenously added UDPGA resulted in a mod- 
erate increase of p-nitrophenol glucuronidation 
(1.33 f 0.32 nmol/min/lO’ cells, mean & SD., n = 4) 
which was likely attributable to the permeation of 
UDPGA into the unviable cells. i.e. cells permeable for 
Trypan blue. 
In alamethicin-permeabilized hepatocytes the high 
rate of p-nitrophenol glucuronidation indicated that 
alamethicin permeabilized not only the plasma mem- 
brane but the endoplasmic reticulum membranes as 
well. To further validate this possibility. p-nitrophenol 
UDPGT and mannose 6-phosphatase activities were de- 
tected in alamethicin-permeabilized cells. To this end 
isolated hepatocytes were permeabilized with various 
concentrations of alamethicin (0.01 to 0.5 mg/ml) and 
p-nitrophenol UDPGT and mannose 6-phosphatase ac- 
tivities were measured. Maximal activation was reached 
at 0.2 mg/ml alamethicin concentration in both cases 
(Fig. 1). UDPGT activity measured in the presence of 
0.5 mM p-nitrophenol and 4 mM UDPGA in Hanks’ 
medium or in the cytosol-like medium (see section 2) 
gave similar results (data not shown). 
As the permeation of ER membrane seemed to be a 
major limit for the UDPGT activity in isolated hepato- 
cytes, it can be supposed that glucuronidation is regu- 
lated through the modification of the permeability of 
ER membrane towards UDPGA. Since dibutyryl cyclic 
AMP was reported to inhibit the glucuronidation of 
p-nitrophenol [16,17], we have also examined whether 
this effect was related to a decreased UDPGA penetra- 
tion through the ER membrane. 
As it was observed previously [ 171. preincubation of 
intact hepatocytes with dbcAMP (1 mM) inhibited the 
glucuronidation of p-nitrophenol. The inhibitory effect 
Table I 
Glucuromdation of p-mtrophenol m intact. saponin- and alamethicm-treated isolated mouse hepatocytes 
Treatment 
Control 
p-Nttrophenol glucuronidation 
(nmol/min/lOh cells) 
dbcAMP pretreated + UDPNAG 
Mannose 6-phosphatase 
acttvity 
(nmol/min/lOh cells) 
None 
Sapomn 
Alamethicin 
0.94 + 0.32 0.32 f 0 17 N.M. N.M. 
2.77 * 0.68* 2.12 f 0 55* 8.37 * 0.11 17+ 5 
26.5 + 4.8 21.6 ? 5.2 NM 413 * 22 
Hepatocytes ( lOh cells/ml) were permeabihzed m the presence of 0.005% saponm or 0.02% alamethtcin for 5 mm. Dtbutyryl cychc AMP (dbcAMP. 
1 mM) was added to the cells 5 mm prtor to the addttion of the permeabihzing agents. Glucuronidation was measured m the presence of 0 1 mM 
p-nitrophenol and. m the case of permeabilized cells only, 4 mM UDPGA plus or minus 1 mM UDPNAG. In Intact cellsp-nitrophenol glucuronide 
formation was measured at 10 mm of mcubatton. In permeabilized cells p-nitrophenol disappearance was measured at 5 (saponin) or at 1 mm 
(alamethicin) of mcubatton. To evaluate mannose 6-phosphatase activtty cells were washed and resuspended in the phosphate-free, KCl-MOPS 
medium and were permeabthzed as above After permeabthzation. P, formatton 1 min after the addttion of 1 mM mannose 6-phosphate was 
measured. Data are means ? S.D. of 5 (p-mtrophenol glucuronidatton) or 3 (mannose 6-phosphatase) experiments N.M = not measured. *Statis- 
tically sigmficant dtfference: P < 0.01 
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Fig. 1. Effect of alamethicin on p-nitrophenol UDPGT and mannose 
6-phosphatase activtty in isolated mouse hepatocytes. Hepatocytes 
( lOh cells/ml) were incubated in the presence of the indtcated concen- 
trations of alamethtcm. UDPGT and mannose 6-phosphatase activtty 
were measured as detailed m the legend to Table 1. except that 
UDPGT activity was evaluated at 3 min of incubation with 0.5 mM 
p-mtrophenol. Data are means f S.D. of 4 (UDPGT) or means of 2 
(mannose 6-phosphatase) experiments. 
due to dbcAMP-preincubation was still present in cells 
subsequently permeabilized by saponin, but was no 
more evident in cells subsequently permeabilized by 
alamethicin (Table I). 
4. DISCUSSION 
In vivo and in intact isolated hepatocytes glucu- 
ronidation is regulated by the level of UDPGTs and the 
availability of UDPGA. UDPGA availability can be 
influenced by the synthesis of the cofactor or by its 
access to the active site of the enzyme. The existence of 
the latter possibility has been proved true in microsomal 
preparations but it was uncertain in intact hepatocytes. 
In the present paper we have shown that selective 
permeabilization of the plasma membrane of hepato- 
cytes by saponin, accompanied with the addition of 
UDPGA, caused about a threefold increase of glucu- 
ronidation. This stimulatory effect is probably due to 
the relatively higher (extrareticular) UDPGA concen- 
tration attained after plasma membrane permeabiliza- 
tion as 4 mM UDPGA was added to the medium; in 
intact hepatocytes the cytosolic UDPGA concentration 
was reported to be around 0.5 mM [l&20]. A similar 
stimulatory effect was reported in hepatocytes treated 
with another plasma membrane permeabilizing agent, 
i.e. filipin [21]. Saponin and filipin are widely used as 
selective plasma membrane permeabilizing agents; their 
effect is based on complex formation with cholesterol in 
the membranes of animal cells. The treatment is highly 
selective for the plasma membrane. because, relative to 
intracellular membranes, it is enriched in cholesterol. 
Although little permeabilization of the ER membrane 
cannot be excluded, we measured high latency of man- 
nose 6-phosphatase activity (4% of the total) in saponin- 
permeabilized cells. An additional sensitive marker of 
the intactness of the ER membrane, the stimulatory 
effect of UDPNAG on UDPGT activity [22]. was also 
present in saponin-treated cells. Indeed, this effect ap- 
pears to be caused by the facilitation of UDPGA trans- 
port through the intact ER membrane [23]. 
Permeabilization of hepatocytes with alamethicin 
caused a tenfold enhancement of UDPGT activity com- 
pared to the saponin-treated cells. Alamethicin is a 
pore-forming antibiotic [24,25] and its effect is inde- 
pendent on the cholesterol content of the membrane. 
Alamethicin appeared to permeabilize both the plasma 
and the ER membranes, as revealed by the full activa- 
tion of the intrareticular mannose 6-phosphatase. The 
optimal alamethicin concentration was the same, 0.2 
mg/ml, in the unmasking of both mannose 6-phospha- 
tase and p-nitrophenol UDPGT activity. 
The inhibitory effect of dbcAMP on p-nitrophenol 
glucuronidation in intact hepatocytes [16,17] was re- 
tained following plasma membrane permeabilization by 
saponin, but was lost following the permeabilization of 
ER (and plasma membrane) by alamethicin. This indi- 
cates that the target of the inhibitor is the permeability 
of the ER membrane for UDPGA, perhaps an UDPGA 
transporter protein [26]. 
The use of alamethicin-permeabilized cells has some 
advantage over the conventional microsomal systems. 
First, it renders the measurement of the total cellular 
UDPGT activity possible while during the preparation 
of microsomes at least the nuclear activity is lost. The 
maximal activity measured in alamethicin-treated cells 
(approx. 36/min/106 cells) would correspond to an activ- 
ity of the ER in situ of 125 nmol/min/mg protein micro- 
somal activity when calculated with 1.7 mg protein/106 
cells and 20% ER protein. This activity is much higher 
than that measured in detergent activated liver micro- 
somes (approx. 40 nmol/min/mg protein) or even in 
alamethicin permeabilized microsomes (approx. 60 
nmol/min/mg protein: R. Fulceri, G. Banhegyi, J. 
Mandl and A. Benedetti, unpublished work). Secondly, 
the method may be suitable for the detection of glucu- 
ronidation in cells of low UDPGT activity. 
The results in the present study indicate that the phe- 
nomenon of latency does exist in isolated intact hepato- 
cytes; the permeability of the ER membrane for 
UDPGA is rate limiting for UDPGT activity and it is 
a possible regulation site in the control of glucuronida- 
tion. Based on the mechanism of permeabilization of 
saponin or alamethicin it is less probable that these 
agents would modify the sideness of ER membranes. 
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